MedPath

OMVOH 300 MG CONCENTRADO PARA SOLUCION PARA PERFUSION

OMVOH 300 MG CONCENTRADO PARA SOLUCION PARA PERFUSION

Commercialized
Register Number

1231736001

Prescription Type

Uso Hospitalario

Authorization Date

Jun 27, 2023

Dosage Form

CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1231736001
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

MIRIKIZUMABActive
Quantity: 300 mg
Name: MIRIKIZUMAB

ATC CLASSIFICATION (3)

L04A
L04AC
L04AC24

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.